World's Best Scientists 2026 revealed!
Nikolai V. Naoumov

Nikolai V. Naoumov

D-Index & Metrics

Microbiology

D-Index
64
Citations
16073
World Ranking
2596
National Ranking
63

Nikolai V. Naoumov publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Nikolai V. Naoumov sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 220 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Nikolai V. Naoumov D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Nikolai V. Naoumov sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Nikolai V. Naoumov is affiliated with Novartis in Switzerland. The primary area of their research is within medicine, with a specific focus on epidemiology and hepatology. Their contributions also span pathology and forensic medicine, as well as studies related to animal science, zoology, endocrinology, diabetes, and metabolism.

The scientist's work primarily addresses various aspects of liver disease, including diagnosis and treatment, immunity related to liver diseases, transplantation, and prognosis. Studies also cover hepatocellular carcinoma treatment and hepatitis B virus investigations. Research on the effects of alcohol consumption on health and animal virus infections form part of their broader academic inquiry.

Nikolai V. Naoumov has co-authored publications with notable frequent collaborators, including Elaine Chng, Dean Tai, Arun J. Sanyal, Yayun Ren, and Dominique Brees.

Their scholarship has been published in several prominent journals, with multiple articles appearing in the Journal of Hepatology. Other venues include Nature Medicine, Hepatology, Clinical Gastroenterology and Hepatology, and Gut.

Recent publications by or involving Nikolai V. Naoumov include:

  • Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH, 2022, Journal of Hepatology
  • IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab, 2024, Clinical Gastroenterology and Hepatology

Other relevant papers, though authored primarily by collaborators but reflective of the research environment, include:

  • Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial, 2023, Nature Medicine
  • Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study, 2023, Hepatology
  • High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy, 2024, Gut

Best Publications

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

    Mala K. Maini;Carolina Boni;Chun Kyon Lee;Juan R. Larrubia

  • Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

    Edward J. Gane;Bernard C. Portmann;Nikolai V. Naoumov;Heather M. Smith

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • A longitudinal analysis of hepatitis C virus replication following liver transplantation

    E. J. Gane;N. V. Naoumov;K.-P. Qian;M. U. Mondelli

  • Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

    Emmet B. Keeffe;Stefan Zeuzem;Raymond S. Koff;Douglas T. Dieterich

  • Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C

    Matthew E. Cramp;Siegbert Rossol;Shilpa Chokshi;Shilpa Chokshi;Patrizia Carucci

  • Presence of a newly described human DNA virus (TTV) in patients with liver disease

    Nikolai V Naoumov;Elena P Petrova;Mark G Thomas;Roger Williams

  • Hepatitis C Virus Persistence after Spontaneous or Treatment-Induced Resolution of Hepatitis C

    Tram N. Q. Pham;Sonya A. MacParland;Patricia M. Mulrooney;Helen Cooksley

  • Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.

    G. Zeng;Z. Wang;S. Wen;J. Jiang

  • Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen–positive patients

    Karsten Wursthorn;Mechthild Jung;Antonio Riva;Zachary D. Goodman

  • Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

    Stefan Zeuzem;Edward Gane;Yun Fan Liaw;Seng G. Lim

  • CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions

    Sandra Phillips;Shilpa Chokshi;Antonio Riva;Alexander Evans

  • Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e‐antigen seroconversion

    Alexander Evans;Antonio Riva;Helen Cooksley;Sandra Phillips

  • Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections

    Ute-Christiane Meier;Rachel E. Owen;Elizabeth Taylor;Andrew Worth

  • Precore mutant hepatitis B virus infection and liver disease

    Nikolai V. Naoumov;Ralf Schneider;Thilo Grötzinger;Maria C. Jung

  • Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.

    George K.K. Lau;Deepak Suri;Raymond Liang;Eirini I. Rigopoulou

  • Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

    Matthew E. Cramp;Patrizia Carucci;James Underhill;Nikolai V. Naoumov

  • A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.

    Edward J. Gane;Su-Kong Lo;Stephen M. Riordan;Stephen M. Riordan;Bernard C. Portmann

  • Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

    M E Cramp;P Carucci;S Rossol;S Chokshi

  • The role of virus-specific CD8+cells in liver damage and viral control during persistent hepatitis B virus infection

    M K Maini;C Boni;K Lee;Larrubia

Frequent Co-Authors

Roger Williams
Roger Williams Foundation for Liver Research
Jinlin Hou
Jinlin Hou Southern Medical University
Ching-Lung Lai
Ching-Lung Lai University of Hong Kong
Bernard Portmann
Bernard Portmann King's College London
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Graeme J. M. Alexander
Graeme J. M. Alexander University College London
George K. K. Lau
George K. K. Lau Humanity & Health
Geert Maertens
Geert Maertens Biocartis (Belgium)
Stephen Locarnini
Stephen Locarnini Melbourne Health
Mark G. Thomas
Mark G. Thomas University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities in healthcare and science. One practical option is pursuing an online medical billing and coding certificate fast. This certification provides a quick pathway into administrative roles within medical facilities, complementing a science background.

Additionally, many learners consider broader healthcare fields. There are numerous online healthcare degrees available that offer flexibility and specialization options, such as public health or health informatics, which align well with microbiology knowledge.

If you’re looking to advance quickly in public health, exploring online MPH programs easy to get into can be an excellent choice. These programs often provide accessible entry points and can enhance career prospects in epidemiology and disease control.

Career pathways related to microbiology also include roles focused on patient care and support, such as child life specialists. Understanding how much do child life specialists make and the steps to enter this field can guide microbiology graduates interested in holistic healthcare roles.

Best Scientists Citing Nikolai V. Naoumov

Trending Scientists

Recently Published Articles